Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Music-based interventions (MBIs) have shown promise in enhancing cognitive and behavioural functions in patients with mild cognitive impairment (MCI). This review aims to synthesize current knowledge on the clinical application of MBIs in MCI and explore their potential use in patients with chronic kidney disease (CKD). A systematic search was conducted in the PubMed, PsycInfo, Cochrane Library and Scopus databases for studies published between January 2013 and October 2023. The search focused on MBIs applied to MCI and CKD patients. We collected data on study design, type of MBIs administered and main clinical outcomes. Sixteen studies were included in this review, ten of which were randomized controlled trials. MBIs ranged from passive music listening (four studies) to active participation in music-making (vocal or singing activities, playing instruments and improvisation, music interventions associated with physical activity, musical stimulation). While no studies specifically focused on CKD patients, cognitive improvements were generally more significant with active interventions, whereas behavioural benefits were more associated with receptive approaches. MBIs showed potential benefits in improving cognitive and depressive symptoms associated with MCI. Given the high prevalence of MCI in CKD patients, future studies should investigate the application of MBIs in this population.

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfaf041DOI Listing

Publication Analysis

Top Keywords

ckd patients
12
music-based interventions
8
mild cognitive
8
cognitive impairment
8
kidney disease
8
application mbis
8
mci ckd
8
mbis
7
cognitive
6
patients
5

Similar Publications

Chronic kidney disease (CKD), heart failure (HF) and atherosclerotic cardiovascular disease (ASCVD) are pathologies that may remain silent for a long time and thus are largely underdiagnosed in clinical practice. The use of biomarkers may help detect people already suffering from these diseases at an early stage or at increased risk to develop them in a near future. The aim of this article is to discuss the place of the assays of albuminuria, natriuretic peptide (BNP/proBNP) and high-sensitivity troponin as well as lipoprotein(a) to help in the diagnosis and prognosis assessment of individuals at risk of presenting or developing a CKD, HF or ASCVD.

View Article and Find Full Text PDF

Aims: Diabetes is a global public health crisis, especially when it is accompanied by microvascular complications such as diabetic kidney disease (DKD). The purpose of this study was to explore the relationship between the combined lifestyle factors of diabetes patients and their joint effects with genetic risk and the risk of DKD.

Materials And Methods: We included individuals diagnosed with diabetes at baseline from UK Biobank.

View Article and Find Full Text PDF

Assessment of GFR Estimation Methods in Patients with Obesity.

J Clin Endocrinol Metab

September 2025

AURA (Association pour l'Utilisation du Rein Artificiel dans la région parisienne), F-75014 Paris, France.

Purpose: Obesity is an independent risk factor for chronic kidney disease, and accurate estimation of the glomerular filtration rate (GFR) is crucial. However, limited data are available on the performance of the European Kidney Function Consortium (EKFC) equation in individuals with overweight or obesity. We evaluated the performance of the EKFC equation by comparing its estimated GFR (eGFR) to values obtained from the 2021 Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation and machine learning (ML) models, using measured GFR (mGFR, obtained via plasma iohexol clearance) as a reference standard in a cohort of patients with overweight or obesity.

View Article and Find Full Text PDF

Introduction And Objectives: Acute kidney injury (AKI) after liver transplantation (LT) impacts patient and graft outcomes. The Albumin-Bilirubin (ALBI) score, an objective and sensitive liver function index, may help predict post-LT outcomes. This study evaluated the association between neohepatic ALBI scores and renal outcomes in living donor LT (LDLT) recipients.

View Article and Find Full Text PDF

Shenqi Wan inhibits cellular senescence to alleviate renal fibrosis by modulating the AQP1/TGF-β1/ITPR1 axis.

Phytomedicine

September 2025

School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310000, China; Academy of Chinese Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. Electronic address:

Background: Renal fibrosis is a common terminal pathway for various CKDs. Shenqi Wan (SQW) can reduce the development of renal fibrosis and may be associated with aquaporin 1 (AQP1) as discovered previously.

Purpose: The mechanism of SQW in mitigating the progression of renal fibrosis and alleviating CKD was analyzed.

View Article and Find Full Text PDF